Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 20Terminated 11Active not recruiting 5Recruiting 4Unknown 3Withdrawn 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Pancreatic Neoplasms 15Breast Neoplasms 13Ovarian Neoplasms 5Stomach Neoplasms 4Esophageal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 3Neoplasm Metastasis 3Esophageal Squamous Cell Carcinoma 3Uterine Cervical Neoplasms 2Neoplasms 2Melanoma 2Advanced Pancreatic Cancer 2Thoracic Neoplasms 1Stage IA Pancreatic Adenocarcinoma 1Squamous Cell Carcinoma of Lung 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Second Line Treatment of Gastric Cancer 1Sarcoma 1Resectable Biliary Tract Cancer 1Pathologic Complete Response 1Pancreatic Adenocarcinoma 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Muscle-Invasive Bladder Carcinoma 1Lung Diseases 1HR+/HER2- Breast Cancer 1HER2+ Breast Cancer 1

Interventions

Fluorouracil 18Oxaliplatin 17Capecitabine 16Leucovorin 13Cisplatin 12Gemcitabine 11Drug Therapy 11Irinotecan 10Radiosurgery 9Cetuximab 9Bevacizumab 9pembrolizumab 8Docetaxel 8Everolimus 7spartalizumab 6Sunitinib 6Radiotherapy 6Paclitaxel 6Neoadjuvant Therapy 6Cyclophosphamide 6Trastuzumab 5S 1 (combination) 5Nivolumab 5Immunotherapy 5Immune Checkpoint Inhibitors 5Chemotherapy, Adjuvant 5Carboplatin 5palbociclib 4manganese chloride 4Surgical Procedures, Operative 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Neoplasm Metastasis × Albumin-Bound Paclitaxel × Clear all
NCT03567720 2023-06-01

Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC

OncoSec Medical Incorporated

Phase 2 Unknown
65 enrolled
Breast

Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT03487016 2022-09-08

FOOTPATH

Ludwig-Maximilians - University of Munich

Phase 2 Unknown
270 enrolled
Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT01964534 2017-01-31

AFUGEM

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 2 Unknown
114 enrolled
Gastrointestinal

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡